share_log

HC Wainwright & Co. Maintains Buy on Evofem Biosciences, Raises Price Target to $4

Benzinga Real-time News ·  Aug 15, 2022 06:38

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Evofem Biosciences (OTC:EVFM) with a Buy and raises the price target from $2 to $4.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment